- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
21
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
21 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDP | US$337.28 | -2.5% | 8.2% | US$10.4b | US$347.92 | PE28.6x | E10.8% | n/a | ||
500488 | ₹28,637.70 | -0.07% | 26.8% | ₹608.5b | ₹28,331.43 | PE47.4x | E10.9% | 1.4% | ||
ORNBV | €42.78 | 2.2% | 8.9% | €6.0b | €50.00 | PE18.1x | E9.7% | 3.8% | ||
500660 | ₹2,284.50 | 1.3% | 30.1% | ₹387.0b | ₹2,914.50 | PE57.3x | E16.8% | 1.4% | ||
688278 | CN¥70.91 | 4.5% | 37.9% | CN¥28.8b | CN¥85.76 | PE38.9x | E32.0% | 0.6% | ||
PTGX | US$41.49 | 1.0% | 86.6% | US$2.4b | US$57.50 | PE14.5x | E-36.0% | n/a | ||
AGIO | US$35.42 | -9.1% | 48.0% | US$2.0b | US$57.29 | PE3x | E-57.3% | n/a | ||
MDXG | US$9.10 | -0.7% | 2.2% | US$1.3b | US$13.40 | PE16.8x | E-1.9% | n/a | ||
500126 | ₹5,450.35 | -4.0% | 10.1% | ₹90.5b | n/a | PE41.6x | E11.3% | 2.2% | ||
JSLL | ₹2,260.10 | -3.8% | 274.4% | ₹56.2b | n/a | PE66.7x | n/a | 0.2% | ||
HVO | UK£0.20 | -9.4% | -11.7% | UK£133.7m | UK£0.34 | PE7.7x | E-29.6% | 1.0% | ||
GRIN | CA$0.99 | 6.5% | 175.0% | CA$211.2m | n/a | PE39.7x | n/a | n/a | ||
93M1 | €22.40 | -5.1% | 38.7% | €98.5m | €108.00 | PE0.8x | E-65.7% | 5.4% | ||
EZZ | AU$2.91 | 10.2% | 381.0% | AU$134.3m | AU$5.45 | PE19.3x | E17.9% | 1.0% | ||
INDSWFTLAB | ₹107.11 | -5.5% | 10.4% | ₹6.3b | n/a | PE1.7x | n/a | n/a | ||
A067290 | ₩1,665.00 | 5.0% | -32.4% | ₩84.4b | n/a | PE11.5x | n/a | 0% | ||
6817 | NT$90.10 | -2.0% | -9.2% | NT$1.7b | n/a | PE11.1x | n/a | 7.3% | ||
690 | HK$0.062 | -1.6% | -13.9% | HK$370.2m | n/a | PE3.7x | n/a | n/a | ||
C4XD | UK£0.12 | 45.9% | -16.4% | UK£30.3m | UK£0.48 | PE2.9x | E-88.3% | n/a | ||
SCNI | US$3.40 | -0.6% | -50.2% | US$2.9m | n/a | PE0.6x | n/a | n/a | ||
CPTR | CA$0.69 | 40.8% | -54.0% | CA$2.4m | n/a | PE0.1x | n/a | n/a |
Page 1 of 1